Shengjie Lin

Shenzhen, 518036, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Evaluation of the diagnostic value of three YiDiXie tests in prostate cancer: an observational prospective single-center study.

Evaluation of the diagnostic value of three YiDiXie tests in prostate cancer: an observational prospective single-center study.

Journal: Scientific reports

Published: September 30, 2025

Assessing the diagnostic performance of YiDiXie™ tests for detecting metastasis across multiple cancer types: A prospective observational single-center study.

Assessing the diagnostic performance of YiDiXie™ tests for detecting metastasis across multiple cancer types: A prospective observational single-center study.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: September 17, 2025

Application of serum miRNA panel in bladder cancer detection.

Application of serum miRNA panel in bladder cancer detection.

Journal: Translational andrology and urology

Published: August 11, 2025

Evaluation of the diagnostic performance of YiDiXie™ tests in urothelial carcinoma.

Evaluation of the diagnostic performance of YiDiXie™ tests in urothelial carcinoma.

Journal: European journal of medical research

Published: June 15, 2025

Testing the accuracy of a three-miRNA panel for the detection of primary prostate cancer: a discovery and validation study.

Testing the accuracy of a three-miRNA panel for the detection of primary prostate cancer: a discovery and validation study.

Journal: Future oncology (London, England)

Published: June 06, 2025

A three-miRNA panel in serum: Serving as a novel diagnostic method for nasopharyngeal carcinoma.

A three-miRNA panel in serum: Serving as a novel diagnostic method for nasopharyngeal carcinoma.

Journal: The International journal of biological markers

Published: April 15, 2025

A panel of three serum microRNAs as a potential diagnostic biomarker for renal cell carcinoma.

A panel of three serum microRNAs as a potential diagnostic biomarker for renal cell carcinoma.

Journal: Scientific reports

Published: February 27, 2025

Evaluation of the diagnostic value of a three-miRNA panel in prostate cancer: a discovery and validation study.

Evaluation of the diagnostic value of a three-miRNA panel in prostate cancer: a discovery and validation study.

Journal: Discover oncology

Published: November 29, 2024

Potential biomarker for screening nasopharyngeal carcinoma: three-microRNA panel in serum.

Potential biomarker for screening nasopharyngeal carcinoma: three-microRNA panel in serum.

Journal: Translational cancer research

Published: November 09, 2024

Serum mature microRNA panel: A novel approach for primary prostate cancer diagnosis.

Serum mature microRNA panel: A novel approach for primary prostate cancer diagnosis.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: November 05, 2024

Panel containing three serum microRNAs: a promising biomarker for early detection of bladder cancer.

Panel containing three serum microRNAs: a promising biomarker for early detection of bladder cancer.

Journal: Frontiers in oncology

Published: July 25, 2024

Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.

Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.

Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals

Published: May 20, 2024

Showing 1-12 of 19

Last Updated: 09/26/2026